Get the latest Venture Capital & Angel investors news and info Join Our Mailing List:

Your Name: 

Your Email:  

*By submitting your name & email you agree to receive for FREE our scholarships & offers Newsletters. You agree also with the storage and handling of your data by this website and 3rd party email services.
You may unsubscribe if you wish. And you can delete your email and name at any time by emailing us to the email on the bottom of this page.

Follow us on
 
  • Altea Therapeutics Raised $33 in third round Venture Capital

    December 30th, 2005 1 comment

    Altea Therapeutics has been named a winner of a Georgia Biomedical Partnership (GBP) Deal of the Year award for a venture capital financing that raised almost $33 million, the largest venture capital deal in Georgia for 2005.

    Altea Therapeutics, an emerging pharmaceutical company developing transdermal patches for the delivery of proteins and water-soluble drugs, raised $32.8 million in a third round of venture capital financing led by Aperture Venture Partners. The investor syndicate also included previous investors Domain, Venrock and vSpring Capital together with KBC, Quilvest, CX Ventures and Rockport Ventures.

    Altea will use the additional resources to continue the clinical development of its lead products for pain management and diabetes control, and also to support the further development of processes for the fabrication of its commercial products. The company is conducting Phase 2 clinical trials in the U.S. with a daily hydromorphone patch for rapid management of moderate to severe pain and Phase 1 clinical trials in the U.S. with insulin patches that provide continuous delivery of basal levels of insulin for people with diabetes.

    The Altea Therapeutics deal was part of increased venture capital funding of life sciences companies in Georgia in 2005. Three of the four largest venture capital deals, and one-half of the money raised in the top 10 deals, went to life sciences companies in 2005.

    The Deal of the Year recognizes transactions, such as financings, collaborations, acquisitions and sales of businesses that represent significant successes by members of Georgia’s biosciences community.

 

1 responses to “Altea Therapeutics Raised $33 in third round Venture Capital” RSS icon

  • Hi there, You have performed an incredible job. I?ll certainly digg it and in my opinion recommend to my friends. I am confident they’ll be benefited from this website.


Leave a reply

Please leave these two fields as-is:

Protected by Invisible Defender. Showed 403 to 251,567 bad guys.

 

Latest Headlines:

Friday August 31, 2012
Zscaler Secures $38 Million Investment Round


Wednesday November 30, 2011
Health Care Solutions companies Infinity Pharmaceutics, NanoVobronix and Selventa raise funds.


Monday November 21, 2011
Panda Power opens $420 Million Fund for Solar and Natural Gas Projects


Thursday November 17, 2011
Better Place raises $200 Million for Electric Cars in the Series C of Funding


Wednesday November 16, 2011
Accel Partners raise $100 Million Big Data Fund to Invest in Hadoop, NoSQL and other Companies


Tuesday November 15, 2011
Skimlinks raises $4.5 Million to help Bloggers Increase their Gains


Monday November 14, 2011
Standing Cloud raises $3 Million to help New Cloud Providers grow Faster


Thursday November 10, 2011
Zillow acquires Diverse Solutions for $7.8 to help Real Estate Agents increase their Visibility


 

By using this website you agree with our cookie policy